Form 4 for HTFL Heartflow, Inc.
Accepted 2026-09-21 18:19:36 ET · period of report 2026-09-18 · accession 0001464521-26-000152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-21 18:19 | 2026-09-18 | HTFL | Rogers Campbell | Chief Medical Off | M - OptEx | $7.94 | +13.2K | 99.6K | +15% | +$104.6K |
| DT | 2026-09-21 18:19 | 2026-09-18 | HTFL | Rogers Campbell | Chief Medical Off | S - Sale+OE | $50.15 | -19.7K | 80.0K | -20% | -$987.1K |
| DMT | 2026-09-21 18:19 | 2026-09-18 | HTFL | Rogers Campbell | Chief Medical Off | M - OptEx | $0.00 | -13.2K | 70.8K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-18 | M | A | 12,329 | $8.33 | 98,788 | D | — | — | (F1) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. |
| 2 | Common | Common Stock | 2026-09-18 | M | A | 850 | $2.22 | 99,638 | D | — | — | (F1) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. |
| 3 | Common | Common Stock | 2026-09-18 | S | D | 19,682 | $50.15 | 79,956 | D | — | — | (F2) Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. |
| 4 | Derivative | Stock Option | 2026-09-18 | M | D | 12,329 | $0.00 | 31,456 | D | $8.33 · — to 2030-02-28 | 12,329 Common Stock | (F1) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. (F3) These stock options are fully exercisable. |
| 5 | Derivative | Stock Option | 2026-09-18 | M | D | 850 | $0.00 | 70,783 | D | $2.22 · — to 2033-07-10 | 850 Common Stock | (F1) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. (F4) The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date. |